Making medicines safer--the need for an independent drug safety board.
Wood
A J
AJ
Vanderbilt University Medical Center, Nashville, TN 37232-6602, USA.
Stein
C M
CM
Woosley
R
R
D016265:Conflict of Interest; D020372:Dexfenfluramine / Q000009:adverse effects; D017277:Drug Approval / Q000331:legislation & jurisprudence; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000379:methods / Q000592:standards*; D017366:Serotonin Receptor Agonists / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D017366:Serotonin Receptor Agonists; D020372:Dexfenfluramine